Literature DB >> 8119087

[Systematic extended lymph node dissection in curative therapy of stomach cancer].

F P Gall1, P Hermanek.   

Abstract

On 545 patients with gastric carcinoma treated surgically for cure during June, 1, 1982 and December, 31, 1989 the value of the systematic extended lymph node dissection (SELD) was studied prospectively. In SELD neither surgical mortality nor postoperative complications were observed with increasing frequency. In stage II survival was significantly improved in patients with SELD, in stages IA, IB and IIIA an analogous trend was seen. Patients in stage IIIB and IV showed with and without SELD identical survival.

Entities:  

Mesh：

Year:  1993        PMID： 8119087

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


  5 in total

Review 1.  Lymphadenectomy for gastric cancer in clinical trials: update.

Authors:  J D Roder; J J Bonenkamp; J Craven; C J van de Velde; M Sasako; K Böttcher; H J Stein
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

2.  Extended gastrectomy: who benefits?

Authors:  F Köckerling; T Reck; F P Gall
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

Review 3.  pTNM and residual tumor classifications: problems of assessment and prognostic significance.

Authors:  P Hermanek
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications.

Authors:  K Günther; T Horbach; S Merkel; M Meyer; U Schnell; P Klein; W Hohenberger
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 5.  News of TNM and its use for classification of gastric cancer.

Authors:  P Hermanek; C Wittekind
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.